Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Bilateral Prophylactic Oophorectomy

Surgical removal of both non-diseased ovaries with the goal of preventing ovarian carcinoma.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
  • G. Cai, Y. Xu, +5 authors S. Cai
  • Colorectal disease : the official journal of the…
  • 2011
  • Corpus ID: 246129
Aim  In this study we explored the prognostic impact of synchronous bilateral prophylactic oophorectomy in female patients with… Expand
Highly Cited
2007
Highly Cited
2007
BACKGROUND Women with BRCA1 or BRCA2 (BRCA1/2) mutations can reduce cancer incidence and mortality by using bilateral… Expand
Highly Cited
2005
Highly Cited
2005
PURPOSE Bilateral prophylactic oophorectomy (BPO) is widely used for cancer risk reduction in women with BRCA1/2 mutations. Many… Expand
Highly Cited
2005
Highly Cited
2005
The clinical outcome of contralateral prophylactic mastectomy (CPM) in women with a BRCA1 or BRCA2 mutation and a personal… Expand
  • table 2
  • table 1
  • table 3
  • figure 1
  • table 3
Highly Cited
2004
Highly Cited
2004
PURPOSE Data on the efficacy of bilateral prophylactic mastectomy for breast cancer risk reduction in women with BRCA1 and BRCA2… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Highly Cited
2003
Highly Cited
2003
PURPOSE Despite the widespread availability of genetic testing for BRCA1/BRCA2 mutations, little is known about the impact of… Expand
Highly Cited
2002
Highly Cited
2002
BACKGROUND Data concerning the efficacy of bilateral prophylactic oophorectomy for reducing the risk of gynecologic cancer in… Expand
Review
2000
Review
2000
  • T. Rebbeck
  • Journal of clinical oncology : official journal…
  • 2000
  • Corpus ID: 5617807
The availability of genetic testing for inherited mutations in the BRCA1 and BRCA2 genes provides potentially valuable… Expand
Highly Cited
2000
Highly Cited
2000
  • T. Rebbeck
  • European journal of cancer
  • 2000
  • Corpus ID: 26906063
 
Highly Cited
1999
Highly Cited
1999
BACKGROUND The availability of genetic testing for inherited mutations in the BRCA1 gene provides potentially valuable… Expand